Latest News

Oxford ‘unicorn’ Nanopore secures £100m

12th December 2016

All News | Financial News | Spinouts & Startups

Handheld DNA sequencer developer Oxford Nanopore secures £100m in funding, valuing the company at £1.25bn.

Oxford Biodynamics completes flotation on AIM

9th December 2016

All News | Financial News | Spinouts & Startups

Biomarker spinout Oxford Biodynamics holds successful flotation on AIM.

EnzBond launches to make fast, effective enzyme development a reality

5th December 2016

All News | Spinouts & Startups | Technology News

Oxford University forms spinout company to bring fast, cost-effective enzyme development to market.

Oxford spinouts’ collaboration leads to breakthrough in genome sequencing

2nd December 2016

All News | Spinouts & Startups | Technology News

Oxford University spinouts Genomics and Nanopore partner on utilising handheld nanopore technologies for DNA sequencing.

Mexican superfood tops Humanities Innovation Challenge

29th November 2016

All News | Spinouts & Startups | Startup Incubator

Mexican superfood startup Azure wins inaugural Humanities Innovation Challenge.

Atopix Therapeutics acquired by Chiesi Farmaceutici

21st November 2016

All News | Financial News | Spinouts & Startups

Atopix Therapeutics Limited, a UK biotechnology company with roots back to Oxford University, has been acquired by Italian pharmaceutical firm Chiesi Farmaceutici Spa.

Oxford Cancer Biomarkers announces ColoTox test for predicting cancer chemotherapy toxicity

9th November 2016

All News | Spinouts & Startups

Oxford Cancer Biomarkers, spun out from Oxford University in 2011 to develop tests for personalised medicine in cancer patients, has enrolled its first patient in a clinical study.

Oxford spinout to develop cancer therapies which reprogram tumours to die

19th October 2016

All News | Financial News | Spinouts & Startups

Oxford spinout Argonaut Therapeutics is developing cancer drugs which reprogram cancer cells to undergo the body’s natural process of cell death, shrinking tumours. The company will focus on treatments for colorectal cancer and lymphoma.

Genomics plc appointed as Analysis Partner for Genomics England GENE Consortium

17th October 2016

All News | Spinouts & Startups

Genomics plc, a 2014 spinout company that is developing an integrated platform to uncover the relationships between genetic variation and human disease, has been appointed as Analysis Partner for the Genomics England Genomics Expert Network for Enterprises (GENE) Consortium.

Oxford spinout develops smart glasses giving legally blind the ability to read and navigate

27th July 2016

All News | Spinouts & Startups

University spinout OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

News

Ready to get in touch?